Chipiron is a developer of advanced portable MRI machines that utilize cutting-edge quantum detectors to generate high-resolution three-dimensional anatomical images. By operating at ultra-low magnetic fields, these machines are designed to be lightweight and cost-effective, significantly reducing the price compared to traditional MRI systems. Chipiron's technology aims to enhance disease detection, diagnosis, and treatment monitoring, particularly for brain-related conditions, thereby assisting healthcare institutions in improving patient outcomes and potentially decreasing fatality rates associated with these ailments.
Astrape Networks
Grant in 2025
Astrape powers the future of datacenters: more bandwidth, less power.
Sparrow Quantum
Series A in 2025
Sparrow Quantum Aps. is a Danish company focused on advancing quantum technology through the development of light-matter interfaces. It specializes in creating deterministic single-photon sources, which are essential for various quantum applications. The company boasts the highest efficiency in on-chip single-photon sources globally, characterized by superior photon purity, indistinguishability, and outcoupling capabilities. This innovative technology is the culmination of over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which Sparrow Quantum holds exclusive licenses to key patents. By leveraging self-assembled quantum dots integrated with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interaction, providing clients with advanced solutions for their quantum technology needs.
QuantWare
Series A in 2025
QuantWare is a leading provider of quantum hardware, specializing in the development of scalable quantum processors. The company is known for its VIO QPU scaling technology, which supports the Quantum Open Architecture paradigm and facilitates the rapid advancement of quantum computing capabilities. With a focus on a 3D-dimensional chip architecture, QuantWare offers fully packaged quantum processing units (QPUs) and various Foundry and Packaging Services. This technology enables customers across 20 countries to build scalable quantum computers that can address complex real-world challenges in fields such as climate science and life sciences. By providing a robust platform for qubit design, QuantWare aims to unlock the potential for systems exceeding one million qubits, making significant strides in the quantum computing landscape.
PrecisionLife
Grant in 2025
PrecisionLife is a company focused on advancing precision medicine by leveraging its proprietary artificial intelligence platform to enhance the understanding of chronic diseases. It specializes in patient stratification, which allows for the identification of novel subgroups within patient populations, thereby generating insights that inform the discovery of new drug targets and drug repositioning candidates. By utilizing unique and patentable biomarkers, PrecisionLife connects patients with specific disease sub-groups and potential therapies, ultimately aiming to create personalized treatment alternatives. The company’s innovative approach not only drives advancements in biopharmaceuticals but also seeks to improve patient outcomes, enabling individuals to lead longer and healthier lives.
Stablepharma
Grant in 2025
Stablepharma Ltd is a biotechnology company based in Bath, United Kingdom, focused on developing innovative processes for vaccine stabilization. Its technology platform, StablevaX™, transforms existing approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration, addressing significant challenges in cold chain logistics. By enabling pre-dosed and stable vaccine delivery, Stablepharma aims to eliminate waste and reduce costs in the distribution of medical products. The company has identified up to 60 vaccine candidates suitable for its technology and collaborates actively with global vaccine manufacturers, academic institutions, and non-governmental organizations to advance its pipeline of thermostable solutions. Established in 2012, Stablepharma is dedicated to improving access to vaccines for children and adults, while also contributing to reduced carbon dioxide emissions in the healthcare sector.
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Deeploy is a developer of a machine learning operations platform that focuses on making artificial intelligence explainable, trustworthy, and accountable. The company's platform centralizes explainable AI within machine learning operations, enhancing the accountability of AI systems. By providing tools for organizing deployments, addressing model degradation, generating trace logs, and creating custom models and explainers, Deeploy empowers data scientists and users to comprehend the functionality and implications of machine learning models. This capability allows for informed corrections of automated decisions, ensuring that AI systems operate transparently and responsibly.
QDI Systems B.V. is a startup based in Groningen, the Netherlands, focused on developing advanced imaging devices for medical applications using quantum dot technology. The company specializes in creating X-ray sensors that deliver high-contrast and high-resolution imaging, particularly for mammography, while also reducing radiation exposure for patients. QDI Systems aims to provide user-friendly quantum dot materials accompanied by comprehensive instructions for constructing high-performance imaging devices. By leveraging innovative technology, the company enhances the precision of medical imaging, enabling healthcare professionals to obtain critical diagnostic information efficiently and safely.
AlzeCure Pharma
Grant in 2025
AlzeCure Pharma AB is a pharmaceutical company based in Huddinge, Sweden, that specializes in developing drug therapies aimed at treating diseases affecting the central nervous system, with a particular emphasis on Alzheimer's disease. Established in 2012, the company is advancing multiple drug candidates through its research platforms, NeuroRestore and Alzstatin, among others. Current projects include ACD855, which is undergoing Phase I clinical trials for sleep disruptions, traumatic brain injuries, and Alzheimer's disease, along with several other candidates targeting Alzheimer's: ACD856, ACD679, and ACD680. Additionally, AlzeCure is developing ACD857 for eye and ear conditions, and VR1 for neuropathic pain, alongside TrkA-NAM for osteoarthritic pain. Through its focused research initiatives, AlzeCure Pharma aims to address significant unmet medical needs in neurodegenerative diseases.
Elicera Therapeutics
Grant in 2025
Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.
TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.
Photon IP is a deeptech startup located in Eindhoven, the Netherlands, specializing in the development of advanced technologies for photonics applications. The company focuses on creating application-specific semiconductors that cater to various industries, including automotive and telecommunications. Its innovative products are designed to enhance the production of wearable electronics and improve data center operations, providing tailored solutions that address the evolving needs of its clients.
AQLAS is shaping the quantum future and discovering Next-Gen Lasers redefining quantum computing. Our high-quality hardware is set apart by its economical, compact, and efficient nature, thus paving the way for the proliferation of quantum computers.
Hervolution Therapeutics
Series A in 2024
Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.
ION-X is a technology company focused on developing advanced propulsion systems for small spacecraft. It specializes in electric propulsion technologies that utilize the ejection of fully ionized particles, offering high thrust and specific impulse (ISP). The company's innovative approach ensures long operational life and high modularity, making its solutions adaptable for various applications in the aerospace market. Additionally, ION-X aims to provide competitive production costs, facilitating mass production and meeting the increasing demand for efficient thrusters in the satellite industry.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
AISPECO is a Lithuanian company specializing in geospatial monitoring systems for various vehicles including helicopters, planes, UAVs (unmanned aerial vehicles), and terrestrial vehicles. The company develops aerial inspection systems tailored for conducting powerline surveys using both helicopters and drones. Their platform facilitates the capture of multiple-angle optical, infrared, corona, and hyperspectral imagery, enabling clients to perform efficient infrastructure inspections while optimizing helicopter operations for endurance and scale.
Quantune Technologies
Grant in 2024
Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.
Turing College
Grant in 2024
Turing College operates as an online educational institution specializing in data science. It offers courses suitable for individuals of varying skill levels and employs an income share agreement model, allowing students to defer payment until they secure employment. The college collaborates with tech companies to co-create its curriculum, providing these partners with real-time student performance updates to facilitate expedited hiring decisions.
National University of Ireland, Maynooth
Grant in 2024
Maynooth University is internationally recognised for quality and value of Their research and scholarship and Their dedication and commitment to teaching and Their students. Part of the NUI and formally established as an autonomous university in 1997, Maynooth University traces its origins to the foundation of the Royal College of St. Patrick in 1795, drawing inspiration from a heritage that includes over 200 years of education and scholarship. The University is a place of lively contrasts. It is a modern institution, dynamic, rapidly-growing, research-led and engaged, yet grounded in historic academic strengths and scholarly traditions.
Hideez is a cybersecurity company that specializes in manufacturing hardware for secure authentication and access control. Based in the USA and Ukraine, the company offers the Hideez Key, a hybrid device that combines wireless authentication, password management, and digital signature capabilities. Utilizing encrypted Bluetooth, RFID, and NFC technologies, the Hideez Key provides a secure, adaptable, and convenient solution for both physical and logical access. It complements existing market solutions and is designed to be platform-agnostic, supporting a wide range of authentication standards.
Sequentia Biotech
Series A in 2024
Sequentia Biotech, founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, is a bioinformatics company based at the UAB Research Park. The company specializes in transforming genomic data into actionable knowledge for various sectors including academic research, plant and animal breeding, and biomedicine. Sequentia serves a diverse client base of over 30 public and private research centers, companies, and hospitals, participating in more than 160 R&D projects. The company offers cloud software, custom software, and bioinformatics consulting services, with notable contributions such as two open-source biodata banks and an award-winning R&D line called Tricopharming, established in 2014. Sanseverino and Aiese have published over 40 scientific articles in high-impact journals, underscoring the company's expertise in omics sciences.
Ephos specializes in manufacturing high-performance integrated photonic circuits using proprietary glass technology. Its products minimize signal loss, facilitating innovative designs for classical and quantum computing applications, as well as quantum communications and sensing. Ephos caters to the computational infrastructure sector, offering tailored, high-quality solutions.
Reverion specializes in the development of innovative, reversible, carbon-negative power plants that harness biogas through patented technology. The company’s containerized units are designed for mass manufacturing and achieve remarkable electrical efficiencies of 80% for both power generation and energy storage. By effectively doubling the electricity output of traditional gas engines, Reverion’s technology not only enhances the performance of existing biogas plants but also mitigates greenhouse gas emissions, resulting in a negative CO2 balance. In addition to generating renewable energy, Reverion’s solutions utilize excess solar and wind power, thereby contributing to grid stability and promoting a renewable and decarbonized future.
Treble Technologies is a company that focuses on advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. It offers specialized acoustics design software that enables the creation of physically accurate and perceptually realistic virtual acoustics. This software aids in minimizing risks and ensuring that designs adhere to all relevant regulations and certification standards. Additionally, it streamlines the process of importing, exporting, and reconfiguring models, ultimately saving time and costs for users. Treble's services find applications across various sectors, including automotive design, building architecture, immersive reality, and artificial intelligence, supporting studios and artists in delivering high-quality projects.
Wattalps is a technology company specializing in the development of lithium power systems tailored for small and medium-scale applications. Their product portfolio focuses on affordability, passive safety measures, efficient cooling mechanisms, extended lifespan, and robust cell protection features. Wattalps aims to simplify integration into vehicles or charging stations by offering standard and modular products, thereby facilitating swift, efficient, and cost-effective adoption of electric vehicle technologies and sustainable transportation solutions.
Oryl Photonics
Grant in 2024
Oryl Photonics specializes in developing laboratory instruments for pharmaceutical and biotech companies. Their core product provides a simple, reliable, and cost-effective method for measuring solubility, contributing to accelerated drug development and improved medicine. The company's unique technology preserves valuable substances during testing, offering a solubility measurement service that empowers researchers to make data-driven decisions and expedite product development.
MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.
Endoron Medical
Series A in 2024
Endoron Medical is a company focused on developing innovative medical devices aimed at enhancing the treatment of abdominal aortic aneurysms. The company specializes in creating an endovascular suture and a fixation device for endografts, which are essential for patients undergoing endovascular aneurysm repair. By employing advanced technology, Endoron Medical aims to provide long-lasting sealing solutions that improve patient outcomes and support healthcare professionals in effectively managing this serious condition.
Innatera is an innovative company specializing in the development of ultra-low power neuromorphic processors designed to replicate the brain's mechanisms for sensory data processing. Founded in 2018 as a spin-off from the Delft University of Technology, the company focuses on creating advanced analog-mixed signal processing architectures. These neuromorphic chips enable sensor data to be processed significantly faster—up to 100 times quicker—while consuming up to 500 times less energy compared to traditional processors. By leveraging the principles of spiking neurons and synapses, Innatera's technology provides businesses with efficient access to real-time sensor data, enhancing their capabilities in various applications.
Qblox is a Dutch scaleup specializing in quantum technology, focused on developing patented solutions for the scalable control of quantum computers. The company designs and manufactures modular control hardware that simplifies the experimental setups involving qubits, employing a distributed processor architecture to enhance gate fidelities. By advancing electronics with improved noise and drift performance, Qblox enables scientists to minimize crosstalk and achieve low-latency arbitrary control flows while optimizing measurement efficiency in dynamic readout conditions. The company aims to address the scientific and engineering challenges that must be overcome to transition from prototype quantum computers to powerful, practical quantum processors.
Bank of Memories
Grant in 2024
Bank of Memories operates a digital platform for long-term preservation of personal data, enabling users to store and organize various forms of digital memories, such as photos, videos, and documents. The platform employs blockchain technology and decentralized storage to ensure data security and longevity, allowing individuals and families to pass on their memories across generations. It offers features like digital monuments for commemorative purposes and a dedicated data room for secure storage, along with an explorer tool for navigating stored information and a whitepaper detailing the platform's technology.
King's College London
Grant in 2024
King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.
ProFuse Technology
Grant in 2024
ProFuse Technology is a developer of advanced cultured meat production technology aimed at transforming traditional meat production methods. The company focuses on enhancing the efficiency of meat production by significantly reducing production time, improving the quality of the meat, and increasing overall yields. By accelerating muscle fiber growth, ProFuse's innovative technology enables meat producers to optimize their processes, leading to cost reductions and increased production capacity. This approach positions ProFuse Technology at the forefront of the cultured meat industry, addressing the growing demand for sustainable and high-quality meat alternatives.
Riverlane is a developer of quantum computing software focused on transforming experimental technology into commercial products. The company engineers innovative instruments in collaboration with quantum computer manufacturers, addressing the need for new hardware and software tools to manage the instability of qubits and rectify system defects at unprecedented speeds. Riverlane's software includes an ultra-low latency quantum operating system that accelerates quantum-classical hybrid algorithms, supporting hardware research and development. Additionally, the company creates algorithms designed to optimize the use of the entire quantum computing stack, assisting hardware partners in minimizing the system errors that currently challenge quantum computing capabilities.
Vitestro is a developer of innovative medical robotic devices focused on enhancing patient care through autonomous blood drawing technology. The company's flagship device employs multi-dimensional ultrasound detection to identify nerves and arteries, utilizing deep learning algorithms to minimize the risk of arterial complications during clinical procedures. This advancement aims to streamline the blood collection process in hospitals and clinical laboratories, ultimately enabling healthcare professionals to perform operations with greater precision and improve overall patient health outcomes.
Vitestro is a developer of innovative medical robotic devices focused on enhancing patient care through autonomous blood drawing technology. The company's flagship device employs multi-dimensional ultrasound detection to identify nerves and arteries, utilizing deep learning algorithms to minimize the risk of arterial complications during clinical procedures. This advancement aims to streamline the blood collection process in hospitals and clinical laboratories, ultimately enabling healthcare professionals to perform operations with greater precision and improve overall patient health outcomes.
Dronamics is a developer of advanced unmanned aerial systems aimed at transforming airfreight logistics. By creating a new type of small, unmanned cargo airplane that is highly fuel-efficient, Dronamics aims to democratize shipping in emerging markets. The aircraft can transport payloads of 350 kilograms over distances of 2,500 kilometers at costs significantly lower than traditional air transport, reducing shipping expenses by over 50%. Designed for autonomous flight, the aircraft can be remotely monitored and managed via satellite, making it suitable for challenging delivery scenarios, including remote and mountainous regions. As the first and only Strategic Partner for drones recognized by IATA, Dronamics is positioned to make a substantial impact in the commercial logistics sector.
RS Research is a clinical-stage biotechnology company based in Istanbul, Turkey, focused on developing innovative nanomedicines for cancer treatment. Founded in 2015, the company has established a proprietary drug delivery platform known as Sagitta®, which enhances the therapeutic index of its drug candidates. RS Research’s pipeline includes multiple proprietary programs at various stages of preclinical and clinical development, with its lead candidate, RS-0139, currently undergoing Phase I clinical trials in oncology patients. The company also offers a range of services, including preclinical absorption and metabolism assessments, bioanalytical testing, and patent consulting. Additionally, RS Research operates a GMP-certified production facility for the manufacture of clinical batch drug candidates and actively engages in co-development projects with international partners.
Multiverse Computing
Series A in 2024
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Established in 2019, the company specializes in creating quantum computing software that leverages probabilistic and nondeterministic technologies to address complex challenges in various sectors, particularly finance. Multiverse Computing's software solutions are designed for portfolio optimization, risk analysis, and market simulation, enabling clients in industries such as banking, energy, manufacturing, and logistics to harness the power of quantum computing. By focusing on these tailored applications, the company aims to facilitate advancements in solving financial and macro-economic problems, positioning itself as a key player in the emerging quantum technology landscape.
Smart Farm Robotix
Grant in 2024
Smart Farm Robotix specializes in manufacturing agricultural robots that tackle the challenges of manual weeding, herbicide use, and machine weeding. Their robots provide a cost-effective, reliable, and fully automated solution, equipped with innovative weed detection and elimination technology. This enables farmers to cultivate crops more efficiently and sustainably, while reducing dependence on manual labor and harmful chemicals.
FreezeM is a company focused on advancing the use of insects as a sustainable protein source for the animal feed industry. Recognizing the potential of insects to address the growing demand for alternative protein, FreezeM develops innovative preservation technologies that facilitate large-scale freezing of insect species. This process aims to create a reliable supply of ready-to-use suspended neonates and frozen eggs, akin to agricultural seed production, which can overcome challenges related to availability, cost, and regulatory constraints. By establishing global stocks of beneficial insects, FreezeM supports various applications, including protein for animal feed, biological pest control, and species preservation, ultimately contributing to a more sustainable food system.
Daze is an engineering startup focused on creating innovative solutions for electric vehicle charging. Its flagship product, DazePlug, is an automatic charging device that utilizes smart charging ecosystems and energy management systems. This technology enables automatic inductive charging, significantly reducing the time required to charge electric vehicles while eliminating the need for manual handling of cables. DazePlug features a retrofit design that is both waterproof and dustproof, ensuring durability and ease of use. By simplifying the charging process, Daze aims to enhance user experience and convenience for electric vehicle owners.
Brite Solar
Series A in 2024
Brite Solar is a nanomaterials company focused on developing advanced transparent solar glass technology for greenhouse and building applications. By utilizing innovative materials and deposition techniques, Brite Solar has created glass that not only generates electricity but also enhances energy efficiency in buildings by reducing the energy required for heating, cooling, and lighting. Its primary market involves the creation of solar glass for greenhouses, which enables these structures to produce their own electricity, significantly lowering energy costs and minimizing reliance on external power sources. This self-sufficient technology can reduce operational costs for greenhouse operators by up to 28%, while also contributing to a negative carbon footprint in crop production. Additionally, Brite Solar's technology is adaptable for future applications, including auto-dimming glass and architectural glass solutions for construction.
Aldoria specializes in space situational awareness, focusing on the collection, processing, and utilization of data to protect vital assets in orbit. The company addresses the growing challenges of space sustainability caused by increasing space debris and traffic. Aldoria's services encompass the detection, tracking, and cataloging of artificial satellites and space debris, as well as assessing collision risks. By providing a new-generation platform for space situational awareness and comprehensive sustainability reports, Aldoria empowers operators and space organizations to navigate safely and effectively, helping them avoid potential hazards and make informed decisions regarding orbital maneuvers.
Wavess is an innovative predictive marketing analytics platform that utilizes advanced artificial intelligence technologies to assist businesses in anticipating the success of their marketing campaigns prior to launch. The platform integrates sophisticated AI algorithms with behavioral science to deliver personalized recommendations that improve engagement and conversion rates. Targeting digital marketing agencies, scale-ups, and enterprises within the fintech, retail, and technology sectors, Wavess offers critical insights into audience preferences and effective customer segmentation. Its unique features, such as pre-launch prediction and ideal customer profiling, empower users to optimize campaign outcomes and develop tailored marketing strategies. Additionally, Wavess analyzes audience demographics and campaign trends to create personalized posting schedules, enhancing overall campaign performance.
NETRIS Pharma
Series A in 2023
NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, focused on the identification and development of therapeutic molecules aimed at treating various forms of cancer. Established in 2008, the company specializes in targeting dependence receptors, which are trans-membrane proteins that play a crucial role in cellular signaling and tumor control. NETRIS Pharma conducts both in vitro and in vivo research, as well as preclinical practices, to manufacture drugs specifically for the treatment of breast cancer, lung cancer, glioblastoma, and neuroblastoma. Through its innovative approach, the company aims to advance cancer therapies and contribute to improved patient outcomes in the pharmaceutical industry.
Lotus Microsystems
Series A in 2023
Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug and play solutions enable our customers to innovate their electronics without worrying about power supply units.
RespiQ is a healthtech startup focused on developing portable, non-invasive breath analysis technology for the early detection and management of respiratory diseases. The company employs advanced emission spectroscopy and artificial intelligence to identify volatile organic compounds in breath, facilitating real-time detection of conditions such as COPD exacerbations. RespiQ emphasizes affordability, portability, and user-friendliness to democratize access to advanced diagnostics, thereby enhancing patient outcomes and reducing healthcare costs. In addition to its primary focus on respiratory diseases, RespiQ's versatile platform technology has potential applications for conditions such as asthma, lung cancer, and infectious diseases. The company also offers an intuitive app that provides personalized health insights, allowing users to monitor changes in their health and make informed dietary choices, ultimately empowering individuals to improve their overall well-being.
Efenco is a cleantech startup focused on enhancing the energy conversion efficiency of industrial furnaces and boilers while minimizing their carbon emissions. The company has developed a patented high-energy ray ceramic chip (HERC) that significantly reduces CO2 emissions and fuel costs by at least 18% in energy-intensive sectors, including electricity generation, steel manufacturing, pulp and paper production, ceramics, cement, and district heating. By leveraging principles from quantum and plasma physics, nanotechnology, and electrochemistry, Efenco's innovative technology captures and converts waste heat generated during natural gas combustion into a flux of ionizing radiation, thereby enabling industries to optimize energy usage and improve thermal conversion efficiency.
NEOGAP Therapeutics
Grant in 2023
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
Acorai is a medical device company focused on developing a non-invasive heart failure monitoring platform that centers around direct intracardiac pressure monitoring (ICPM). The company utilizes a unique combination of sensor technologies and machine learning to enable accurate and cost-effective heart failure management. Acorai's technology allows for the non-invasive monitoring of cardiac and pulmonary pressure through the analysis of acoustic, vibratory, and waveform data, making it the only proven method to enhance outcomes for heart failure patients. The device has received clinical validation and has been designated as an FDA Breakthrough Device, with plans to enter the market in 2025. By enabling healthcare professionals to proactively adjust medications, Acorai aims to reduce both the rates of heart failure re-hospitalization and mortality.
Skytree is a company focused on developing innovative solutions for carbon dioxide capture and recycling. Founded in 2014, it leverages over a decade of research originally aimed at addressing CO2 challenges for astronauts on the International Space Station. Skytree specializes in direct air capture (DAC) technology that efficiently extracts carbon dioxide from ambient air. This technology supports a circular carbon supply, enabling businesses that need CO2 for their operations to reduce reliance on fossil fuels. By providing a reliable source of usable carbon dioxide, Skytree contributes to the transition toward a more sustainable future and a healthier planet. The company boasts a diverse team of skilled scientists, engineers, and business professionals, all guided by an experienced management team.
ResoTher Pharma
Grant in 2023
ResoTher Pharma is a privately held biotechnology company based in Copenhagen, Denmark. The company specializes in developing peptide-based drugs derived from Annexin A1, an endogenous immunomodulator. These drugs are designed as resolution therapies for diseases where neutrophil-driven inflammation is a key pathological factor. ResoTher Pharma's primary focus is on addressing cardiovascular and inflammatory disorders that have significant unmet medical needs. Their patented peptide drugs target a G-protein coupled receptor expressed on leukocytes, aiming to mimic the body's natural response to resolving inflammation and promoting tissue repair.
RAIKU Packaging
Grant in 2023
RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.
FarmInsect
Series A in 2023
FarmInsect GmbH, established in 2019 and headquartered in Bergkirchen, Germany, specializes in automated insect breeding systems. The company develops machines and IoT solutions that enable regional farmers to rear insects on-site for use as animal feed, primarily for chickens, pigs, and fish. This sustainable approach aims to replace imported soy or fishmeal with locally produced protein feed, thereby enhancing the efficiency of animal husbandry while reducing environmental impact.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
PrediSurge
Series A in 2023
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.
Kern Tec is a manufacturer specializing in the upcycling of fruit kernels derived from stone fruits such as cherries, apricots, and plums. The company refines these kernels into high-quality raw materials, creating a range of products including baking ingredients, sustainable cosmetic oils, fertilizers, and biomass. By focusing on environmentally friendly practices, Kern Tec provides clients in the baking, food supplement, dairy alternatives, and confectionery industries with naturally sourced ingredients while minimizing environmental impact. Their innovation allows for the creation of new food products from what would otherwise be waste, contributing to a more sustainable food supply chain.
Swisspod Technologies
Grant in 2023
Swisspod Technologies SA is a transportation development firm based in Monthey, Switzerland, founded in 2019. The company specializes in designing and developing energy-efficient Hyperloop systems, which are innovative tube-based transportation solutions aimed at providing high-speed travel between distant cities. Swisspod's Hyperloop pods are fully electric and designed to be sustainable and affordable, emphasizing environmental responsibility and economic viability. The firm is committed to advancing high-speed transportation through cutting-edge Swiss engineering and is assembling a team of multidisciplinary experts dedicated to revolutionizing the future of travel.
UPMEM is a fabless semiconductor company focused on enhancing the performance of data-intensive applications through its innovative Processing-In-Memory (PIM) technology. By integrating a large number of programmable co-processors directly next to data storage, UPMEM's solution significantly accelerates data processing tasks, achieving performance improvements of over ten times compared to traditional server architectures. This technology addresses the limitations imposed by data movement in data centers, making it particularly effective for analytics and artificial intelligence applications. UPMEM's platform not only reduces off-chip data movements but also contributes to lower energy consumption and a smaller hardware footprint, making it an attractive option for leading global application developers and cloud service providers.
Bound4Blue
Series A in 2023
Bound4Blue is a pioneering marine technology company that develops foldable and autonomous wingsail systems for integration onto various vessels. Their innovative system harnesses existing wind power to generate thrust, reducing main engine usage by up to 40%. This results in significant fuel consumption and pollutant emission reductions, with an average payback period of less than five years. The technology also facilitates clean hydrogen production through seawater electrolysis.
Paptic is a manufacturing company focused on creating innovative, wood-based renewable and recyclable products that aim to replace traditional paper and plastic materials. By developing plastic bags that merge the renewability and recyclability of paper with the functional benefits of plastics, Paptic addresses critical global environmental challenges, particularly the accumulation of plastic waste. The company's products enable customers to pursue sustainable practices without compromising their everyday needs for plastic bags.
INBRAIN Neuroelectronics
Grant in 2023
INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, founded in 2019. It specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. The company has created the world's first graphene-based brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation. This innovative technology allows for real-time monitoring and adaptive, personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. By utilizing AI-driven solutions, INBRAIN maximizes therapeutic outcomes while minimizing side effects. The company is also expanding its capabilities through strategic partnerships, including collaborations with Merck KGaA and its subsidiary INNERVIA Bioelectronics, to explore applications in peripheral nerve and systemic diseases, advancing the field of neurotechnology and bioelectronics.
STABL
Venture Round in 2023
Stabl Energy is a technology developer focused on enhancing battery storage systems for renewable energy applications. The company specializes in manufacturing virtual battery inverters that improve the efficiency and deployment of energy storage solutions. By setting new standards for battery storage, Stabl Energy's products enable clients to connect central inverters to the power grid, significantly reducing self-consumption and preventing dangerous high battery voltages. This innovation allows users to fully utilize their battery capacity, thereby maximizing energy efficiency and contributing to the broader adoption of renewable energy technologies.
Pulse is a platform for furthering our understanding of bioprinting and its applications in space exploration and medicine.
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in developing advanced imaging technologies. The company focuses on light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. Wooptix's platform enables the three-dimensional modulation of images, allowing for higher data points at elevated frame rates in volumetric images and videos. This technology facilitates enhanced image quality and advanced post-processing capabilities, providing users with innovative ways to interact with and visualize their environments. Wooptix aims to improve human experiences through its cutting-edge imaging solutions.
ELGAN Pharma
Grant in 2023
Elgan Pharma is a biotechnology company specializing in neonatology, primarily focused on addressing the medical challenges faced by premature infants. The company develops innovative therapies using nanotechnology aimed at preventing visual impairment, a significant concern for preterm babies. By targeting the multifactorial causes of visual disabilities, Elgan Pharma enables healthcare professionals to improve visual outcomes and reduce the risk of long-term disabilities in this vulnerable population. Through its advancements in late-stage development, the company is committed to enhancing the quality of care for premature infants and addressing critical developmental difficulties associated with their early birth.
Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.
Twinsity is a developer of a platform designed to visualize, inspect, and collaboratively manage high-resolution drone data and digital twins. The company focuses on enhancing infrastructure inspections and lifecycle management through the integration of artificial intelligence. Its virtual 3D inspection software provides accurate insights by consolidating a comprehensive image database, allowing all stakeholders involved in the inspection process to collaborate effectively. By centralizing communication, documentation, and inspection activities, Twinsity enables clients to streamline their operations, thereby improving the management and oversight of structures and assets.
Cellbox Solutions
Grant in 2023
Cellbox Solutions is a technology company that specializes in innovative logistic solutions for the global BioMed industry. It has developed a carbon dioxide incubator designed for the storage, isolation, handling, and analysis of biological materials. This incubator offers essential logistic services and ensures the proper handling of living cells, facilitating their storage, reproduction, transportation, and analysis. By enabling the transportation of living cells via various methods, including road, rail, and air, Cellbox Solutions supports healthcare providers in their efforts to deliver the latest therapies to patients.
Woodio is a design-oriented company specializing in innovative material technology for bathroom applications. The company has developed a fully waterproof wood composite made from real wood chips, allowing for a variety of design options while maintaining the aesthetic appeal of natural wood. Woodio's products are fully recyclable, promoting sustainability in bathroom design. By combining functionality with environmental responsibility, Woodio aims to transform how consumers approach bathroom materials and design.
EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.
Escala Medical
Grant in 2023
Escala Medical is focused on developing a pioneering medical device aimed at treating pelvic organ prolapse (POP) in women. The company has created a minimally invasive, incision-free, and mesh-free repair system that addresses the long-standing need for effective POP treatment options. This innovative device allows for a nonsurgical approach that can be performed in outpatient and office settings, ensuring a safe and quick procedure with minimal discomfort for patients. By connecting the vaginal apex to the sacrospinous ligament without incisions, Escala Medical's technology preserves organ functionality while providing a much-needed solution for those affected by POP.
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.
DTE introduces breakthrough real-time process control analytics for metals production and processing towards Industry 4.0, through our robotic hardware and software solutions, automating current manual sampling processes for improved quality, cost, efficiency and safety.
Sensoneo is a global provider of smart waste management solutions designed to help cities and businesses manage waste in a cost-effective and environmentally responsible manner. The company utilizes proprietary ultrasonic smart sensors and sophisticated software to enable real-time monitoring of waste, facilitating data-driven decision-making and optimization of waste collection processes. Sensoneo's technology allows for significant reductions in waste collection costs, with savings of at least 30%, and decreases carbon emissions by up to 60%. The company's solutions have been implemented in various locations worldwide, including Europe, North America, South America, the Middle East, Australia, and New Zealand, attracting a diverse clientele. By automating the waste lifecycle and promoting transparency in waste streams, Sensoneo empowers organizations to adopt eco-friendly practices and implement incentive programs aimed at reducing waste production.
Cupffee is a manufacturer of edible and biodegradable coffee cups and stirrers, designed as a sustainable alternative to traditional disposable cups. The company's innovative production process generates no industrial waste, utilizing only clean steam and the aroma of freshly baked cookies. Additionally, all leftover materials from the cup production are repurposed as ingredients for other edible products. Unlike conventional cups, which can take years to decompose, Cupffee's products break down within days, offering clients an environmentally friendly solution for reducing non-recyclable waste.
The Intelligence Behind Global Circularity VCG.AI transforms industrial by-products and waste into valuable resources. AI-powered development of circular economy business models with the latest technology, material, market, and regulatory insights. Their proprietary AI solution, the Value Chain Generator®, helps companies, cities, and regions accelerate the transition to a circular economy, through Valorisation of By-products and Waste, Circular Product Development, Regional Circular Opportunities Assessment. When organisations want to better valorise by-products and waste, develop or source circular materials, or enhance circularity in their value chains, VCG.AI analyses thousands of data points to deliver the optimal solution tailored to their specific needs and locations. What once took months or years can now be achieved in just weeks—without the need to hire additional technology or bioeconomy experts. VCG.AI’s ever-expanding system includes: - 650+ validated circular solutions - 150+ different proven valorisation technologies - 3.5 M companies - 4M tons of project-ready organic residuals across Europe VCG.AI is on a mission to accelerate the transition to a circular economy by unlocking circular opportunities for businesses worldwide. Learn more about them at www.vcg.ai.
3DSecret is developing cutting-edge technologies to uncover the stochastic patterns behind metastasis in order to predict the course of cancer.
Agurotech specializes in agritech software and soil sensing technology aimed at enhancing agricultural practices. The company provides robust sensing solutions that deliver tailored irrigation recommendations, enabling farmers to optimize water usage and nutrient management based on data-driven insights. By leveraging Internet of Things applications, Agurotech aids farmers in making informed decisions, ultimately improving resource efficiency and increasing productivity. Their focus on data utilization helps unlock valuable information, allowing farmers to enhance their operations and achieve better outcomes in both agricultural and horticultural settings.
Inobiostar focuses on research and experimental development services.
Norbite is a biotechnology research firm that specializes in converting plastic waste into sustainable products through an innovative insect-based biorefinery process. The company's technology enables the production of sustainable goods by utilizing larvae that are bio-refined to extract proteins suitable for food and animal feed. By focusing on the transformation of plastic waste, Norbite aims to provide environmentally friendly solutions while addressing the growing concerns of waste management and sustainability. Through its unique approach, the firm contributes to the development of sustainable products and services that benefit both clients and the environment.
EyeLights
Series A in 2023
EyeLights is a developer of innovative motorcycle accessories focused on enhancing rider safety and experience through advanced technology. The company offers a head-up display GPS that projects crucial navigational and safety information directly into the rider's field of vision, allowing them to maintain focus on the road. This universal accessory alerts motorcyclists to potential hazards, such as sharp bends, traffic signals, and speed limits. Designed for easy installation in under five minutes, EyeLights is compatible with various helmet types, including full-face, convertible, and jet helmets. Its compact optical technology enables visibility of GPS data from over two meters away and features audio functionality for extended use of more than eight hours. The device is built to withstand adverse weather conditions, including rain and fog, while remaining lightweight at less than 100 grams. Overall, EyeLights aims to significantly enhance the safety and enjoyment of motorcycle riding.
Naco Technologies Ltd is a manufacturer and supplier of advanced nano-coating technologies, specializing in high-performance coatings for various industries including tooling, automotive, aerospace, and microchip production. Founded in 2009 and headquartered in Riga, Latvia, Naco develops multilayer and multicomponent coatings that enhance equipment performance by providing oil-enhanced, wear-protective, thermal barrier, and liquid-repellent properties. The company plays a significant role in the hydrogen sector by creating specialized coatings for Green Hydrogen systems, such as electrolyzers and fuel cells, which improve the reliability of these systems while minimizing the use of costly and scarce materials. In 2015, Naco Technologies was acquired by the Schaeffler Group, a Germany-based company, further strengthening its capabilities and market reach.
Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.
Nemysis Limited is a specialty pharmaceutical company based in Dublin, Ireland, founded in 2005. The company focuses on addressing unmet needs in nutritional disorders and deficiencies through a staged approach to product development. Nemysis manufactures food supplements, medical matrix products, and prescription items, targeting the same conditions across different market segments. Among its innovative offerings are a gastric and trypsin-resistant glutenous product for oral enzymatic therapy aimed at celiac disease patients, as well as an iron supplement designed to minimize gastrointestinal side effects associated with iron supplementation. Additionally, the company is developing a glutenous medical device that effectively destroys gluten, helping to prevent symptoms in individuals with celiac disease and non-celiac gluten sensitivity.
Smart Immune
Grant in 2023
Smart Immune is a clinical-stage biotechnology company dedicated to advancing hematopoietic stem cell-based biotherapies aimed at improving the prognosis and quality of life for patients with severe diseases. The company's primary focus is on its innovative cell therapy program that utilizes T cell progenitors, known as ProTcells, which are designed to facilitate a rapid and safe immune recovery following transplantation. This program is complemented by integrative developments in targeted conditioning, gene therapy, and genome editing, allowing for the creation of next-generation treatments. Smart Immune's approach aims to provide effective allogeneic T-cell therapies for patients suffering from life-threatening conditions, particularly hematological malignancies and primary immune deficiencies.
Inbiome is a trailblazing company in molecular diagnostics, specializing in proprietary molecular culture technology. This innovation enables swift bacterial testing and microbiome analysis, significantly expediting the process compared to traditional methods. The company's primary mission is to advance clinical microbiology by focusing on microbial detection and product development, thereby guiding clinicians towards more accurate and timely diagnoses. By offering advanced molecular technology for microbiome analysis, Inbiome aids in enhancing the understanding of bacteria in the human body, facilitating correct treatments, and mitigating unnecessary complications, costs, and anti-microbial resistance.
Quantune Technologies
Grant in 2023
Quantune Technologies is a deep tech startup specializing in optics and photonics technology. The company focuses on developing advanced infrared spectrometers that facilitate continuous and non-invasive health monitoring. By miniaturizing traditional laboratory equipment used for molecular analysis into compact modules, Quantune enables both biomedical consumer devices and industrial applications. This innovation allows clients to efficiently conduct real-time monitoring and analysis of chemical compounds and emissions, providing accessible solutions for a range of novel applications.
Miwa is a company that offers a comprehensive retail solution aimed at reducing waste through the use of reusable containers. Its innovative approach focuses on minimizing single-use packaging by employing a circular economy strategy. Miwa's reusable containers are designed to be sealable and hygienic, working in conjunction with electronic dispensers installed in retail environments for the distribution of both food and non-food products in bulk. This system allows producers and retailers to store and dispense goods more sustainably, aligning with modern environmental standards while promoting efficient retail practices.
Molecular Attraction
Grant in 2023
Molecular Attraction is a research and development firm focused on creating innovative solutions for vector-borne disease control and eradication. The company specializes in identifying biological compounds that can influence the behavior of various vector organisms, including mosquitoes, ticks, flies, and rodents. By utilizing sustainable technology and chemical blends, Molecular Attraction aims to provide effective, long-lasting, and low-maintenance pest control solutions. Their approach is designed to enhance the efficacy of vector-borne disease management while prioritizing environmental sustainability and cost-effectiveness within the pest control industry.
GrayMatters Health
Grant in 2023
GrayMatters Health is a health technology company focused on developing digital therapeutics for mental disorders by enabling volitional regulation of brain processes. The company aims to address mental health and neurological disorders through its innovative solutions, which empower healthcare professionals with neuroscience-based technology. By targeting brain biomarkers associated with these conditions, GrayMatters Health enhances the efficacy, safety, and accessibility of mental healthcare. This approach provides patients with streamlined treatment options, allowing them to manage their disorders more effectively and conveniently.
Qurv, established in 2020, specializes in developing advanced image sensor technologies and integrated solutions. The company's core business is enabling next-generation computer vision applications, catering to the growing demands of autonomous and intelligent systems. Qurv's innovative technology, built on over eight years of research, leverages current CMOS manufacturing and advanced materials to deliver high-performance, reliable, and functional solutions for XR devices, service robots, and automotive industries.
Sunrise is a medical technology company focused on improving the diagnosis and management of sleep disorders, particularly sleep apnea, which affects nearly one billion people worldwide. The company has developed a 3-gram sensor that allows for rapid and accurate at-home diagnosis of sleep conditions, utilizing trigeminal drive analysis to detect respiratory events. This innovative device is clinically validated for use in both adults and children and provides a cost-effective alternative to traditional in-lab sleep studies. Users receive a single-use sensor delivered to their home, which connects easily to their phone for seamless operation. Following the test, Sunrise facilitates consultations with certified sleep doctors or connections to local sleep centers, addressing a critical need in a healthcare landscape where 80% of sleep apnea cases remain undiagnosed.
IDloop specializes in biometric technology, focusing on contactless fingerprint sensor solutions tailored for business and government sectors. The company employs advanced 3D imaging, artificial intelligence, and embedded technology to deliver secure, high-quality multi-finger image capture. By facilitating large-scale biometric data acquisition, IDloop's solutions significantly reduce false acceptance rates, thereby enhancing overall security for its clients.
Valo Therapeutics
Grant in 2023
Valo Therapeutics is an immunotherapy company focused on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Founded in 2016 and based in Oxford, United Kingdom, with an additional office in Helsinki, Finland, the company utilizes its innovative Valo Tx platform, which includes PeptiCRAd, an engineered human oncolytic adenovirus. This platform is designed to induce systemic anti-tumor T cell responses by transforming oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without requiring the production of multiple genetically modified viruses. Valo Therapeutics is also advancing other neoantigen strategies, including PeptiENV, in collaboration with Professor Vincenzo Cerullo from the University of Helsinki, to enhance therapeutic responses against various cancer types.